Heffernan Catherine, Jenkinson Crispin
Health Services Research Unit, Department of Public Health, University of Oxford, Old Road Campus, Headington, OX3 7LF, UK.
Chronic Illn. 2005 Jun;1(2):131-42. doi: 10.1177/17423953050010021001.
Health-related quality-of-life measures have been increasingly used in research into neurological disorders in recent years. The aim of this paper is to provide an objective appraisal of the evidence in regard to disease-specific quality-of-life measures used in research on health interventions for three degenerative neurological disorders: multiple sclerosis, motor neurone disease/amyotrophic lateral sclerosis and Parkinson's disease. A comprehensive search strategy was developed to include nine relevant electronic databases. Only studies pertaining to patient-based outcome measurements in multiple sclerosis, motor neurone disease and Parkinson's disease were included. We identified 76 eligible studies. As studies consisted of descriptive and cross-sectional survey study designs, results were reported qualitatively rather than in the form of a meta-analysis. Four disease-specific measures were found for Parkinson's disease, 11 for multiple sclerosis and one for motor neurone disease. We conclude that health-related quality-of-life measures are useful in assessing the impact of treatments and interventions for neurological disorders. However, further research is needed on the development of instruments using psychometric methods and on the validation, utilization and responsiveness of instruments to change.
近年来,与健康相关的生活质量测量方法在神经系统疾病研究中越来越多地被使用。本文的目的是对用于三种退行性神经系统疾病(多发性硬化症、运动神经元病/肌萎缩侧索硬化症和帕金森病)健康干预研究的疾病特异性生活质量测量方法的证据进行客观评估。制定了一项全面的检索策略,纳入九个相关电子数据库。仅纳入了与多发性硬化症、运动神经元病和帕金森病基于患者的结局测量相关的研究。我们确定了76项符合条件的研究。由于研究包括描述性和横断面调查研究设计,结果以定性方式报告,而非采用荟萃分析的形式。发现针对帕金森病有四种疾病特异性测量方法,针对多发性硬化症有11种,针对运动神经元病有1种。我们得出结论,与健康相关的生活质量测量方法有助于评估神经系统疾病治疗和干预的影响。然而,在使用心理测量方法开发工具以及工具的验证、应用和对变化的反应性方面,还需要进一步研究。